Keyphrases
Advanced Prostate Cancer
100%
Androgen Deprivation Therapy
20%
Anti-androgen Therapy
20%
Antiandrogen
20%
C4-2B
20%
Cabazitaxel
100%
Castration-resistant Prostate Cancer
40%
Cell Death
20%
Chemotherapy
20%
Chemotherapy Resistance
100%
Combinational
20%
Cross-resistance
20%
Differential Gene
20%
DNA Damage
20%
Dynamic Interconversion
20%
E-cadherin Expression
20%
Epithelial Phenotype
20%
Epithelial-mesenchymal Transition
20%
Gene Pathway Analysis
20%
Gene Signature
20%
High-level Expression
20%
Immunohistochemistry
20%
Intracellular Transport
20%
Ispinesib
20%
Kinesin
100%
Low Expression
20%
Microtubule Binding
20%
Mitotic Kinesin
20%
Model Specimen
20%
Molecular Mechanism
20%
Monotherapy
20%
Patient-derived Xenograft
40%
Phenotypic Landscape
20%
Potential Drivers
20%
Prostate Cancer
40%
Prostate Tumor
60%
Protein Regulation
20%
Redifferentiation
20%
Resistant Cells
20%
Resistant Phenotypes
20%
SLCO1B3
20%
Taxane Chemotherapy
40%
Therapeutic Outcome
20%
Transcriptomic Profiling
20%
Vimentin
20%
Medicine and Dentistry
Androgen Deprivation Therapy
20%
Antiandrogen
20%
Antiandrogen Therapy
20%
Cabazitaxel
100%
Cell Death
20%
Cross Resistance
20%
DNA Damage
20%
Immunohistochemistry
20%
In Vitro
20%
Intracellular Transport
20%
Ispinesib
20%
Kinesin
100%
Microtubule
20%
Monotherapy
20%
Prostate Cancer
100%
Prostate Tumor
60%
Transcriptomics
20%
Uvomorulin
20%
Vimentin
20%
Xenograft
40%
Pharmacology, Toxicology and Pharmaceutical Science
Androgen
20%
Antiandrogen
40%
Cabazitaxel
100%
Chemotherapy
60%
Cross-Resistance
20%
Ispinesib
20%
Kinesin
100%
Monotherapy
20%
Prostate Cancer
100%
Prostate Tumor
60%
SLCO1B3
20%
Taxane
40%
Uvomorulin
20%
Vimentin
20%
Immunology and Microbiology
Cadherin
50%
Cell Death
50%
Cross-Resistance
50%
DNA Damage
50%
Intracellular Transport
50%
Microtubule
50%
Prostate
100%
Transcriptomics
50%
Xenograft
100%
Biochemistry, Genetics and Molecular Biology
Cadherin
33%
Cell Death
33%
Cross Resistance
33%
DNA Damage
33%
Gene Signature
33%
Intracellular Transport
33%
Kinesin
100%
SLCO1B3
33%
Transcriptomics
33%
Vimentin
33%